CNS Pharmaceuticals, Inc. Common Stock

CNSP XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

7.2M

Short interest (May 15)

3.8%

Borrow Fee

600.68%

↓ 11.3%

Available Shares

↓ 67.0%

Price Chart

Company Overview

CNS Pharmaceuticals Inc is a biotechnology company focused on developing therapies for serious diseases in neurology and oncology. The company is building a high-value pipeline for neurology and oncology indications. Its new corporate includes pivoting from a singular focus on glioblastoma multiforme and exploring out-licensing opportunities for its legacy assets, TPI 287 and Berubicin.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001729427

Asset Type: CS

Market Data

Market Cap: $7,190,329

Employees: 8

Status: Active

Short Interest

Current Borrow Fee 600.68%

Range: 591.44% - 600.95%

Available Shares 2K

Range: 1K - 4K

Recent Changes

Fee Change: ↓ 4.5%

Available Change: ↓ 60.0%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime